Cargando…
May Circulating microRNAs be Gastric Cancer Diagnostic Biomarkers?
Gastric cancer (GC) is the third leading cause of cancer-related deaths. More than 80% of the diagnosis was made at the advanced stages of the disease, highlighting the urgent demand for novel biomarkers that can be used for early detection. Recently, a number of studies suggest that circulating mic...
Autores principales: | Wu, Xiaoling, Tan, Xiaohui, Fu, Sidney W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622850/ https://www.ncbi.nlm.nih.gov/pubmed/26535061 http://dx.doi.org/10.7150/jca.12535 |
Ejemplares similares
-
Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer
por: Yao, Yunjin, et al.
Publicado: (2021) -
MicroRNAs as Diagnostic Biomarkers in Gastric Cancer
por: Yin, Ying, et al.
Publicado: (2012) -
Circulating microRNAs as potential diagnostic biomarkers for osteoporosis
por: Mandourah, Abdullah Y., et al.
Publicado: (2018) -
Circulating Exosome microRNAs as Diagnostic Biomarkers of Dementia
por: Dong, Xiaoyu, et al.
Publicado: (2020) -
The diagnostic value of circulating microRNAs as a biomarker for gastric cancer: A meta-analysis
por: Wei, Hui, et al.
Publicado: (2019)